Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dac-MSCs for Diabetic Foot Ulcers
NCT02943486Phase 2Unknown
- Sponsor
- Universidad Autónoma de Bucaramanga
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Modality
- Stem Cell Therapies, Small Molecules
01
Overview
A Phase 2 trial of decitabine + mesenchymal stem cells in diabetic foot ulcer (DFU), sponsored by Universidad Autónoma de Bucaramanga. Status: unknown.
02
Drugs
decitabine + mesenchymal stem cells
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02943486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943486.